Human Immunodeficiency Virus Clinical Trials in Cape Town, Western Cape
5 recruitingCape Town, Western Cape, South Africa
Showing 1–5 of 5 trials
Recruiting
Phase 2
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting
Phase 3
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled29 locationsNCT07071623
Recruiting
Universal Test and Connect for HIV Service Delivery in South Africa
Human Immunodeficiency Virus
Johns Hopkins University2,000 enrolled1 locationNCT06408142
Recruiting
Not Applicable
Project Khanya: Peer-Delivered Intervention to Improve HIV Medication Adherence and Substance Use in South Africa
Substance UseDrug UseHuman Immunodeficiency Virus+1 more
University of Maryland, College Park160 enrolled1 locationNCT05933226